Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 201-213

  Lo, Warren D ^a,b   Qu, Guang ^a   Sferra, Thomas J ^a   Clark, Reed ^a   Chen, Ruju ^a   Johnson, Philip R ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b EDU 521 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA GALACTOSIDASE; CAPSID PROTEIN; HYDROXYUREA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; DOSE RESPONSE; DRUG ADMINISTRATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNE RESPONSE; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; TRANSGENE;

ANIMALS; ANTIBODIES, VIRAL; BETA-GALACTOSIDASE; BRAIN; CELL LINE; DEPENDOVIRUS; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HYDROXYUREA; MICE; MICE, INBRED BALB C; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0033585514     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018995     Document Type: Article

References (41)

1. ADAMSON, R.H., AGUE, S.L., HESS, S.M., and DAVIDSON, J.D. (1965). The distribution, excretion, and metabolism of hydroxyurea-14C. J. Pharmacol. Exp. Ther. 150, 322-327.
2. ALEXANDER, I.E., RUSSELL, D.W., SPENCE, A.M., and MILLER, A.D. (1996). Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7, 841-850.
3. BASKAR, J.F., SMITH, P.P., NILAVER, G., JUPP, R.A., HOFFMANN, S., PEFFER, N.J., TENNEY, D.J., COLBERG-POLEY, A.M., GHAZAL, P., and NELSON, J.A. (1996). The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70, 3207-3214.
4. BERNS, K.I., and GIRAUD, C. (1996). Biology of adeno-associated virus. Curr. Top. Microbiol. Immunol. 218, 1-23.
5. CHEN, H., MCCARTY, D.M., BRUCE, A.T., and SUZUKI, K. (1998). Gene transfer and expression in oligodendrocytes under control of the myelin basic protein transcriptional control region mediated by adeno-associated virus. Gene Ther. 5, 50-58.
6. CLARK, K.R., VOULGAROPOULOU, F., FRALEY, D.M., and JOHNSON, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
7. CLARK, K.R., VOULGAROPOULOU, F., and JOHNSON, P.R. (1996). A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther. 3, 1124-1132.
8. CLARK, K.R., SFERRA, T.J., and JOHNSON, P.R. (1997). Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8, 659-669.
9. DOLL, R.F., CRANDALL, J.E., DYER, C.A., AUCOIN, J.M., and SMITH, F.I. (1996). Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Ther. 3, 437-447.
10. DU, B., WU, P., BOLDT-HOULE, D.M., and TERWILLIGER, E.F. (1996). Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther. 3, 254-261.
11. FABRICIUS, E., and RAJEWSKY, M.F. (1971). Determination of hydroxyurea in mammalian tissues and blood. Rev. Eur. Etudes Clin. Biol. 16, 679-683.
12. FERRARI, F.K., SAMULSKI, T., SHENK, T., and SAMULSKI, R.J. (1996) Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
13. FISHER, K.J., JOOSS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 3, 306-312.
14. FLANNERY, J.G., ZOLOTUKHIN, S., VAQUERO, M.I., LAVAIL, M.M., MUZYCZKA, N., and HAUSWIRTH, W.W. (1997). Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 94, 6916-6921.
15. FLOTTE, T.R., AFIONE, S.A., and ZEITLIN, P.L. (1994). Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11, 517-521.
16. FRITSCHY, J.M., BRANDNER, S., AGUZZI, A., KOEDOOD, M., LUSCHER, B., and MITCHELL, P.J. (1996). Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice. J. Neurosci. 16, 2275-2282.
17. GRANT, C.A., PONNAZHAGAN, S., WANG, S.X., SRIVASTAVA, A., and LI, T.S. (1997). Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina. Curr. Eye Res. 16, 949-956.
18. HALBERT, C.L., ALEXANDER, I.E., WOLGAMOT, G.M., and MILLER, A.D. (1995). Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69(3), 1473-1479.
19. HALBERT, C.L., STANDAERT, T.A., AITKEN, M.L., ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1997). Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J. Virol. 71, 5932-5941.
20. HERZOG, R.W., HAGSTROM, J.N., KNUG, S.H., TAI, S.J., WILSON, J.M., FISHER, K.J., and HIGH, K.A. (1997). Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 94, 5804-5809.
21. KAPLITT, M.G., LEONE, P., SAMULSKI, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154.
22. KARPATI, G., LOCHMULLER, H., NALBANTOGLU, J., and DURHAM, H. (1996). The principles of gene therapy for the nervous system. Trends Neurosci. 19, 49-54. [Review]
23. KLATZO, I. (1967). Presidential address: Neuropathological aspects of brain edema. J. Neuropathol. Exp. Neurol. 26, 1-14.
24. LEVIN, V.A. (1992). The place of hydroxyurea in the treatment of primary brain tumors. Semin. Oncol. 19(Suppl. 9):34-39.
25. MCCOWN, T.J., XIAO, X., LI, J., BREESE, G.R., and SAMULSKI, R.J. (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713, 99-107.
26. OKADA. H., MIYAMURA, K., ITOH, T., HAGIWARA, M., WAKABAYASHI, T., MIZUNO, M., COLOSI, P., KURTZMAN, G., and YOSHIDA, J. (1996). Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther. 3, 957-964.
27. PEEL, A.L., ZOLOTUKHIN, S., SCHRIMSHER, G.W., MUZYCZKA, N., and REIER, P.J. (1997). Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther. 4, 16-24.
28. PODSAKOFF, G., WONG, K.K., JR., and CHATTERJEE, S. (1994). Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68, 5656-5666.
29. PONNAZHAGAN, S., ERIKSON, D., KEARNS, W.G., ZHOU, S.Z., NAHREINI, P., WANG, X.S., and SRIVASTAVA, A. (1997). Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8, 275-284.
30. PROSCH, S., STEIN, J., STAAK, K., LIEBENTHAL, C., VOLK, H.D., and KRUGER, D.H. (1996). Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro. Biol. Chem. Hoppe-Seyler 377, 195-201.
31. ROSENFELD, M.R., BERGMAN, I., SCHRAMM, L., GRIFFIN, J.A., KAPLITT, M.G., and MENESES, P.I. (1997). Adeno-associated viral vector gene transfer into leptomeningeal xenografts. J. Neurooncol. 34, 139-144.
32. RUSSELL, D.W., MILLER, A.D., and ALEXANDER, I.E. (1994). Adeno-associated virus vectors preferentially transduce cell in S phase. Proc. Natl. Acad. Sci. U.S.A. 91, 8915-8919.
33. RUSSELL, D.W., ALEXANDER, I.E., and MILLER, A.D. (1995). DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 92, 5719-5723.
34. SLOTNICK, B.M., and LEONARD, C.M. (1975). A Stereotaxic Atlas of the Albino Mouse Forebrain. (Department of Health, Education, and Welfare, Washington, D.C.).
35. SMITH, F.E. and MCCOWN, T.J. (1997). AAV vectors: General characteristics and potential use in the central nervous system. In Gene Transfer and Therapy for Neurological Disorders. E.A. Chiocca and X.O. Breakefield, eds. (Humana Press, Clifton, NJ) pp. 79-88.
36. SNYDER, R.O., MIAO, C.H., PATIJN, G.A., SPRATT, S.K., DANOS, O., NAGY, D., GOWN, A.M., WINTHER, B., MEUSE, L., COHEN. L.K., THOMSPON, A.R., and KAY, M.A. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270-276.
37. TRACEWELL, W.G., TRUMP, D.L., VAUGHAN, W.P., SMITH, D.C., and GWILT, P.R. (1995). Population pharmacokinetics of hydroyurea in cancer patients. Cancer Chemother. Pharmacol. 35, 417-422.
38. VAN DEN BERG, C.L., MCGILL, J.R., KUHN, J.G., WALSH, J.T., DE LA CRUZ, P.S., DAVIDSON, K.K., WAHL, G.M., and VON HOFF, D.D. (1994). Pharmacokinetics of hydroxyurea in nude mice. Anti-Cancer Drugs 5, 573-578.
39. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108.
40. XIAO, X., LI, J., MCCOWN, J.T., and SAMULSKI, R.J. (1997a). Gene transfer by adeno-associated virus vectors into the central nervous system. Exp. Neurol. 144, 113-124.
41. 1 containing receptors and increases inferior collicular seizure sensitivity. Brain Res. 756, 76-83.